Skip to main content

Table 3 Secondary outcomes

From: Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder

 

Prior admissions among the 16 cases with an prior admission in the past 12 months (%)

Index admissions among the 16 cases with an prior admission in the past 12 months (%)

Index admissions among the entire case series cohort (%)

 

n = 42 admissions

n = 16 admissions

n = 23 admissions

Patient-directed discharge (PDD)

29 (69.0)

7 (43.8)

10 (43.5)

Length of stay for PDDs

3.0 days [IQR 1.3–4.2]

5.0 days [IQR 3.0–12.5]

5.0 days [IQR 2.5–8.3]

Discharged on medications for OUD

14 (33.3)

11 (68.8)

15 (65.2)

Discharged with naloxone

8 (19.0)

11 (68.8)

15 (65.2)